Breaking News Instant updates and real-time market news.

VZ

Verizon

$47.90

-0.59 (-1.22%)

10:33
05/15/18
05/15
10:33
05/15/18
10:33

Verizon CEO says 5G 'a lot closer than a lot of people think'

Lowell McAdam said Los Angeles will be Verizon's second city to roll out 5G. Verizon CEO Lowell McAdam is being interviewed on CNBC.

  • 15

    May

VZ Verizon
$47.90

-0.59 (-1.22%)

04/30/18
MSCO
04/30/18
NO CHANGE
MSCO
Morgan Stanley discusses T-Mobile deal implications for competitors, towers
After T-Mobile (TMUS) and Sprint (S) announced a merger agreement, Morgan Stanley analyst Simon Flannery said that while the $43B in estimated synergies is "impressive," the key question is how likely is it that the companies can gain regulatory approval. On competition, he thinks the deal may contribute to a more benign competitive environment in the near-term and that AT&T (T) and Verizon (VZ) could benefit from market consolidation, though he adds that the new T-Mobile would be a formidable competitor in new areas such as 5G and fixed broadband. Flannery added that the deal will be an overhang on tower and fiber providers, noting that part of their $4B in annual network synergies involves a reduction in tower counts from 110,000 to 85,000 over time. However, the analyst said he would expect much more gear to be deployed on each tower and small cells will still expand to 50,000 from 10,000. Tower operators include American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC), which are all lower in pre-market trading.
05/11/18
JPMS
05/11/18
UPGRADE
Target $58
JPMS
Overweight
Verizon upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Philip Cusick upgraded Verizon Communications to Overweight with a $58 price target. The shares at current levels offer a 5% yield and a "free option" on 5G, Cusick tells investors in a research note.
05/11/18
JPMS
05/11/18
UPGRADE
Target $58
JPMS
Overweight
After meeting with CEO, JPMorgan upgrades Verizon to Overweight
JPMorgan analyst Philip Cusick upgraded Verizon Communications to Overweight from Neutral with an unchanged price target of $58. The shares closed yesterday up 81c to $47.20. After meeting with CEO Lowell McAdam, Cusick says he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." Further, the analyst believes Verizon's 5G opportunity "will start to crystallize in the next few months." Cusick expects the company's revenue to stabilize and notes the stock is down 11% this year. The analyst is positive on the 5% dividend yield and "free 5G optionality."
05/11/18
05/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying after a meeting with CEO Lowell McAdam, he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." 2. Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Andrew Wong saying that it is "hard to ignore the improving undercurrents in both phosphate and potash markets." 3. Ultragenyx (RARE) upgraded to Overweight from Equal Weight at Barclays with analyst Gena Wang saying she thinks a higher price target for Crysvita could drive upside to revenue growth expectations. 4. U.S. Bancorp (USB) upgraded to Buy from Neutral at Citi with analyst Keith Horowitz saying now is an opportune time to build positions in the stock after three years of significant underperformance. 5. AMC Networks (AMCX) upgraded to Buy from Hold at Gabelli with the firm saying it remains an excelling company with opportunities to leverage its recent programming momentum into increased advertising and affiliate fees. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ZEAL

Zealand Pharma

$18.48

0.4 (2.21%)

, NVO

Novo Nordisk

$47.44

-0.2 (-0.42%)

08:27
09/19/18
09/19
08:27
09/19/18
08:27
Recommendations
Zealand Pharma, Novo Nordisk analyst commentary  »

Zealand Pharma price…

ZEAL

Zealand Pharma

$18.48

0.4 (2.21%)

NVO

Novo Nordisk

$47.44

-0.2 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$83.89

-1.82 (-2.12%)

08:26
09/19/18
09/19
08:26
09/19/18
08:26
Downgrade
Westlake Chemical rating change  »

Westlake Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLK

Allakos

$44.88

0.95 (2.16%)

08:25
09/19/18
09/19
08:25
09/19/18
08:25
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SPWR

SunPower

$7.55

0.97 (14.74%)

, ENPH

Enphase Energy

$4.35

0.48 (12.40%)

08:24
09/19/18
09/19
08:24
09/19/18
08:24
Recommendations
SunPower, Enphase Energy, First Solar analyst commentary  »

Tariff exemption a…

SPWR

SunPower

$7.55

0.97 (14.74%)

ENPH

Enphase Energy

$4.35

0.48 (12.40%)

FSLR

First Solar

$49.56

1.81 (3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

08:23
09/19/18
09/19
08:23
09/19/18
08:23
Conference/Events
JPMorgan to hold a summit »

India Investor Summit…

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
09/19/18
09/19
08:21
09/19/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
Senate Judiciary vote on Kavanaugh Supreme Court vote cancelled, CNN reports »

The Senate Judiciary…

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$69.82

0.3 (0.43%)

, ZS

Zscaler

$39.79

-0.455 (-1.13%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Conference/Events
William Blair to hold a tour »

Cybersecurity Bus Tour…

OKTA

Okta

$69.82

0.3 (0.43%)

ZS

Zscaler

$39.79

-0.455 (-1.13%)

PANW

Palo Alto Networks

$234.07

2.1 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$207.47

0.89 (0.43%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
U.S. housing starts preview: »

U.S. housing starts…

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
U.S. current account preview: »

U.S. current account…

XLK

Technology Select Sector SPDR

$74.46

0.45 (0.61%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.89

0.52 (0.70%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$116.98

1.5 (1.30%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$59.68

0.065 (0.11%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.37

-0.11 (-0.20%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.72

-0.25 (-0.45%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$86.82

0.58 (0.67%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Recommendations
Skyworks analyst commentary  »

Skyworks underperformance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$93.71

0.5 (0.54%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVB

Civista Bancshares

$22.95

-0.23 (-0.99%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Upgrade
Civista Bancshares rating change  »

Civista Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$170.24

0.68 (0.40%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$262.87

1.89 (0.72%)

08:17
09/19/18
09/19
08:17
09/19/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$290.96

1.55 (0.54%)

08:17
09/19/18
09/19
08:17
09/19/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.